This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Wealth management tips can significantly boost your investment returns. Explore strategies designed for savvy investors.
26,684 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Intuitive Machines stock popped today as analysts weigh backlog, milestones, and funding signals. This article breaks...
As Stanford’s AI Index shows lagging adoption in the U.S., analysts say the real payoff comes from integration and tr...
The 30-year treasury just crossed 5%, triggering a rotation from growth into asset-backed champions. This article fla...
Meta Platforms is navigating a bold AI infrastructure push that could redefine profits. This guide breaks down the ri...
Cypherpunk Technologies reaffirms a 5% ZEC reserve despite a patched Zcash flaw, as investors debate the strategy ami...
Oracle stock faces a pivotal moment as management doubles down on AI infrastructure while financing plans raise dilut...
Nike has been a market darling, then hit a rough patch. This article digs into whether nike stock undervalued right n...
With market volatility intensifying, UDR stands out as a steady-income play. The residential REIT offers a ~4.6% yiel...
Airline equities tumbled in a broad market selloff after West Texas Intermediate crude surged, lifting fuel costs and...
Stocks ended mixed as the Dow stayed relatively calm while Nasdaq slipped. Earnings, rates, and sector rotation shape...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...